Uveal MelanomaSymptoms, Doctors, Treatments, Advances & More
Uveal Melanoma Overview
Learn About Uveal Melanoma
- Intraocular melanoma
- Melanoma of the Uvea
- Uveal melanoma
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Richard Carvajal is a Hematologist and an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Carvajal is currently accepting new patients.
Ophthalmology - Wills Eye Hospital
Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Uveal Melanoma. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.
Sophie Neumann-Piperno practices practicing medicine in Paris, France. Ms. Neumann-Piperno is rated as an Elite expert by MediFind in the treatment of Uveal Melanoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Adult Soft Tissue Sarcoma, Hysterectomy, and Tissue Biopsy.
Summary: This is a randomized, multi-center, open-label study of adjuvant darovasertib in participants with non-metastatic uveal melanoma (OptimUM-11)
Summary: This study is to evaluate the safety and tolerability to determine (i) the recommended Phase 2 dose (RP2D) of VMD-102 (Phase 1), and (ii) preliminary anti-tumor efficacy (Phase 2), in participants with advanced HCC, metastatic uveal melanoma (MUM), renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), and colorectal cancer (CRC). The pharmacokinetics (PK), preliminary anti-tumor activity...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


